SKYA vs BDX vs STVN Stock Comparison

SkyAI, Becton Dickinson and Stevanato Group S.p.A Prices as of Oct 26, 2026 Peers: Industry group
SKYA SkyAI, Inc.
$2.89 +53.7% 1M -42.8% 1Y
Market cap
$206.92M
P/E
–
Revenue (TTM)
$194.22K
Div. yield
–
Medical Supplies Healthcare
2 wins
BDX Becton Dickinson & Co
$196.39 +6.8% 1M +5.7% 1Y
Market cap
$53.61B
P/E
57.0x
Revenue (TTM)
$23.25B
Div. yield
–
Medical Supplies Healthcare
5 wins
STVN Stevanato Group S.p.A.
$19.87 -6.3% 1M -23.9% 1Y
Market cap
$5.36B
P/E
34.1x
Revenue (TTM)
$1.43B
Div. yield
–
Medical Supplies Healthcare
4 wins

Head to Head

11 decided of 12

Becton Dickinson leads on 5 of the 12 questions below (Becton Dickinson 5, Stevanato Group S.p.A 4, SkyAI 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionSKYABDXSTVNLeader
Larger companyMarket capitalisation $206.92M $53.61B $5.36B BDX
Cheaper on earningsLower P/E, profitable companies only -0.7x 57.0x 34.1x STVN
Cheaper on forward earningsLower price / next fiscal year consensus EPS 0.0x 15.1x 30.1x SKYA
Faster revenue growthRevenue growth, trailing twelve months +108.9% +17.4% +14.8% SKYA
More profitableNet margin, trailing twelve months -158,431.4% 4.0% 11.0% STVN
Better return on capitalReturn on invested capital — 5.3% 7.2% STVN
Less leveragedLower net debt / EBITDA — 3.2x 1.2x STVN
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -42.8% +5.7% -23.9% BDX
Better 5-year returnAnnualised price return, 5 years — -4.3%/yr -4.6%/yr BDX
Less volatileAnnualised volatility, 1 year 106.2% 31.9% 45.6% BDX
Higher overall scoreMean of the five percentile scores vs peers 26/100 67/100 66/100 BDX

Percentile Scorecard

SKYABDXSTVN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisSKYABDXSTVN
Valuation 2 #223 of 228 90 #24 of 228 80 #46 of 228
Growth 6 #207 of 221 47 #117 of 221 57 #95 of 221
Profitability 1 #206 of 208 78 #46 of 208 82 #39 of 208
Financial Health 94 #16 of 239 27 #176 of 239 71 #69 of 239
Shareholder Returns – 95 #8 of 137 41 #81 of 137
Overall 26 67 66
  • SKYA ranked among 248 companies in Medical Devices and Diagnostics
  • BDX ranked among 248 companies in Medical Devices and Diagnostics
  • STVN ranked among 248 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodSKYABDXSTVNSPY
1 month +53.7%+6.8%-6.3% -0.8%
3 months +118.9%+23.6%+0.1% +3.5%
6 months +61.5%+30.7%+22.8% +7.0%
Year to date +42.4%+1.2%-1.2% +12.2%
1 year -42.8%+5.7%-23.9% +13.0%
3 years -99.9%-21.9%-30.8% +86.3%
3 years, per year -90.1%-7.9%-11.6% +23.1%
5 years —-19.8%-21.0% +68.6%
5 years, per year —-4.3%-4.6% +11.0%
10 years —+17.2%— +258.0%
10 years, per year —+1.6%— +13.6%

Risk

MeasureSKYABDXSTVNSPY
Volatility, 1Y 106.2%31.9%45.6% 12.7%
Downside volatility, 1Y 104.5%33.1%44.8% 12.7%
Beta vs S&P 500, 1Y 2.590.341.12 1.00
Return / volatility, 1Y -0.400.18-0.52 1.02
Max drawdown, 5Y -100.0%-50.4%-62.2% -25.4%
From 52-week high -46.6%-6.5%-23.5% -1.8%
52-week high $5.41$210.02$25.98 $779.14
52-week low $0.95$140.71$13.43 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleSKYABDXSTVN
P/E now vs peer median -0.7xmedian 30.6x 57.3xmedian 30.6x 34.5xmedian 30.6x
P/S now vs peer median 1,073xmedian 3.0x 2.3xmedian 3.0x 4.2xmedian 3.0x
EV/EBITDA now vs peer median —median 17.5x 14.0xmedian 17.5x 18.6xmedian 17.5x
P/FCF now vs peer median —median 23.3x 16.7xmedian 23.3x 10.1xmedian 23.3x
P/B now vs peer median 1.3xmedian 2.4x 2.2xmedian 2.4x 3.4xmedian 2.4x
PEG now vs peer median 0.01median 0.87 -3.93median 0.87 -128.82median 0.87

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsSKYABDXSTVN
Revenue $194.22K $23.25B $1.43B
Gross profit $321.93K $10.91B $416.82M
Operating income -$289.52M $2.48B $233.97M
Net income -$307.71M $941.00M $157.06M
Free cash flow – $3.20B $592.88M
R&D $399.91K $1.37B $29.75M
EPS (diluted) $-4.27 $3.42 $0.58
Cash & equivalents $12.07M $708.00M $89.82M
Total debt – $72.81B $2.11B
Shares (diluted) 72.09M 275.16M 272.96M
Enterprise value $165.62M $50.76B $4.80B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricSKYABDXSTVN
P/E -0.7x 57.3x 34.5x
P/FCF – 16.7x 10.1x
P/Operating cash flow – 13.5x 20.7x
P/S 1,073x 2.3x 4.2x
P/B 1.3x 2.2x 3.4x
P/Tangible book 16.0x 2.2x 3.5x
EV/EBITDA – 14.0x 18.6x
EV/EBIT -0.7x 28.0x 27.4x
EV/Revenue 1,011x 3.0x 4.5x
EV/FCF – 21.7x 10.8x
EV/Operating cash flow – 17.6x 22.1x
PEG (3Y EPS CAGR) 0.01 -3.93 -128.82

Growth

14 metrics
MetricSKYABDXSTVN
Revenue growth (1Y) 108.9% 17.4% 14.8%
Revenue CAGR (3Y) 23.8% 6.9% 9.8%
Gross profit growth (1Y) – 23.7% 19.4%
Gross profit CAGR (3Y) – 8.5% 6.2%
Operating income growth (1Y) -5,525% 13.0% 17.2%
Operating income CAGR (3Y) -212.8% 3.3% 4.5%
Net income growth (1Y) -42,440% -40.6% 7.5%
Net income CAGR (3Y) -238.0% -17.3% 0.8%
EPS growth (1Y) -487.2% -38.0% 6.7%
EPS CAGR (3Y) -84.2% -14.6% -0.3%
Operating cash flow growth (1Y) – 43.5% 30.4%
Operating cash flow CAGR (3Y) – 14.5% 32.9%
Free cash flow growth (1Y) – 54.2% 17.2%
Free cash flow CAGR (3Y) – 22.5% 8.0%

Profitability

14 metrics
MetricSKYABDXSTVN
Gross margin 165.8% 46.9% 29.2%
EBITDA margin – 21.4% 24.1%
Operating margin -149,065% 10.7% 16.4%
Pretax margin -151,352% 8.4% 15.7%
Net margin -158,431% 4.0% 11.0%
FCF margin – 13.8% 41.5%
Operating cash flow margin – 17.0% 20.3%
Return on equity -140.2% 3.9% 8.9%
Return on assets -137.6% 1.9% 5.3%
Return on invested capital – 5.3% 7.2%
Return on capital employed -136.7% 6.0% –
Asset turnover 0.0x 0.5x 0.5x
Cash conversion (OCF / net income) – 4.2x 1.8x
Stock comp / revenue 48,037% 1.2% –

Financial Health

11 metrics
MetricSKYABDXSTVN
Debt / assets – 33.1% 17.0%
Debt / equity – 0.7x 0.3x
Net debt / EBITDA – 3.2x 1.2x
Debt / FCF – 5.2x 0.9x
Liabilities / assets 1.9% 51.9% 40.8%
Equity / assets 98.1% 48.1% 59.2%
Interest coverage – 4.2x 14.9x
Current ratio 5.3x 0.9x –
Quick ratio 4.4x 0.3x –
Cash ratio 4.2x 0.1x –
Altman Z-score 31.13 2.29 –

Shareholder Returns

7 metrics
MetricSKYABDXSTVN
Dividend yield – 2.1% 0.3%
Net buyback yield – 4.7% –
Shareholder yield – 6.8% 0.3%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusSKYABDXSTVN
Forward P/E 0.0xFY2026 15.1xFY2026 30.1xFY2026
EPS, next fiscal year $2,362.06FY2026 $12.99FY2026 $0.66FY2026
EPS growth, next FY – +14.8%FY2026 +4.8%FY2026
EPS growth, the year after – -2.9% +15.2%
Revenue, next fiscal year $70.01MFY2026 $18.11BFY2026 $1.46BFY2026
Revenue growth, next FY +34,200.1%FY2026 -17.1%FY2026 +5.1%FY2026
Revenue growth, the year after +17.5% +11.6% +10.0%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersSKYABDXSTVN
Held by institutions – 96.1% 16.4%
Institutions holding – 1,442 126
Change in shares held, QoQ – +0.6% +0.4%
Institutions buying – 688 61
Institutions selling – 543 52
Buyers to sellers – 1.27 1.17

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

SKYABDXSTVN
SKYA 1.00 0.12 0.14
BDX 0.12 1.00 0.22
STVN 0.14 0.22 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, SKYA, BDX and STVN?

Becton Dickinson (BDX) is the largest by market capitalisation: SkyAI (SKYA) $206.92M, Becton Dickinson (BDX) $53.61B, Stevanato Group S.p.A (STVN) $5.36B.

Which stock is cheaper, SKYA, BDX and STVN?

Stevanato Group S.p.A (STVN) trades on the lowest price-to-earnings ratio (SkyAI (SKYA) -0.7x, Becton Dickinson (BDX) 57.0x, Stevanato Group S.p.A (STVN) 34.1x). On next year's consensus earnings, SkyAI (SKYA) is cheapest (SkyAI (SKYA) 0.0x, Becton Dickinson (BDX) 15.1x, Stevanato Group S.p.A (STVN) 30.1x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

SkyAI (SKYA) grew revenue fastest over the trailing twelve months: SkyAI (SKYA) +108.9%, Becton Dickinson (BDX) +17.4%, Stevanato Group S.p.A (STVN) +14.8%.

Which company is more profitable?

Stevanato Group S.p.A (STVN) has the highest net margin (SkyAI (SKYA) -158,431.4%, Becton Dickinson (BDX) 4.0%, Stevanato Group S.p.A (STVN) 11.0%). On return on invested capital, Stevanato Group S.p.A (STVN) leads (Becton Dickinson (BDX) 5.3%, Stevanato Group S.p.A (STVN) 7.2%).

Which stock has performed better?

Over the past year Becton Dickinson (BDX) returned the most: SkyAI (SKYA) -42.8%, Becton Dickinson (BDX) +5.7%, Stevanato Group S.p.A (STVN) -23.9%. Over five years, Becton Dickinson (BDX) compounded fastest (Becton Dickinson (BDX) -4.3%/yr, Stevanato Group S.p.A (STVN) -4.6%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Becton Dickinson (BDX) has been the steadiest (SkyAI (SKYA) 106.2%, Becton Dickinson (BDX) 31.9%, Stevanato Group S.p.A (STVN) 45.6%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, SKYA, BDX and STVN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Becton Dickinson (BDX) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.